Business
Why has the Telix (ASX:TXL) share price shot up 5% today?
The Telix Pharmaceuticals Ltd (ASX: TLX) share price is racing higher after the company announced a new phase in its drug trials. The company confirmed it will proceed with the Phase III of ProstACT study for its TLX591 drug, a prostate cancer treatment.
The company also advised this morning that it has entered into a commercialisation and partnership agreement with DuChemBio, a leading South Korean radiopharmaceutical company.
At the time of writing, the Telix share price has surged up 5% to $4.20.
About the Phase III testing
Telix recently met with the United States Food and Drug Administration (FDA) to discuss the company’s planned Phase III ProstACT trial for TLX591. Today’s announcement is the result of that meeting.
The…
-
General7 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
Noosa News21 hours agoProtest calls for shark net removal
-
General20 hours agoThree youths in police custody after fire at Ashley Youth Detention Centre in northern Tasmania
-
Noosa News23 hours agoNew playground equipment encourages children to learn through ‘risky play’